Template:Adult NAC dosing: Difference between revisions
Ostermayer (talk | contribs) (Created page with "====PO==== *140mg/kg PO load *70mg/kg PO q4hr x17 doses additional; dilute to 5% soln ====IV==== *Loading dose: 150mg/kg in 100 mL D5W over 60min *Second (maintenance) dose:...") |
(→PO) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
====PO==== | ====PO==== | ||
* | *Less preferred than IV route due to unpleasant taste and smell | ||
* | *140 mg/kg PO load | ||
*70 mg/kg PO q4hr x17 doses additional; dilute to 5% soln | |||
====IV==== | ====IV==== | ||
Latest revision as of 20:02, 20 April 2020
PO
- Less preferred than IV route due to unpleasant taste and smell
- 140 mg/kg PO load
- 70 mg/kg PO q4hr x17 doses additional; dilute to 5% soln
IV
- Loading dose: 150mg/kg in 100 mL D5W over 60min
- Second (maintenance) dose: 50mg/kg in 250 mL D5W over 4hr
- Third dose: 100mg/kg in 500 mL D5W over 16hr
Comments
- Almost 100% effective if given <8 hr post-ingestion; less effective if 16-24 hr post-ingestion
- May still be useful >24 hr post-ingestion, even with fulminant hepatic failure. Give NAC until LFTs improve (not until APAP level is 0) [1] [2]
- Be aware NAC treatment may affect PT. May see a dose-dependent increase in PT following NAC in patients without hepatotoxicity. [3]
- ↑ Keays R, Harrison PM, Wendon JA, et al. Intravenous acetylcysteine in paracetamol-induced fulminant hepatic failure: a prospective controlled trial. BMJ. 1991;303(6809):1026-1029. (Prospective randomized controlled trial; 50 patients)
- ↑ Harrison PM, Keays R, Bray GP, et al. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of N-acetylcysteine. Lancet. 1990;335(8705):1572- 1573. (Retrospective analysis; 100 patients)
- ↑ Wasserman GS, Garg U. Intravenous administration of Nacetylcysteine: interference with coagulopathy testing. Ann Emerg Med. 2004;44(5):546-547. (Letter)